e-Drug3D 1292 |
IMATINIB
|
cas 152459-95-5 |
CLASS ANTINEOPLASTIC AGENTS |
ROUTE (list) ORAL |
ATC code |
PK parameters F 98 PERCENT Solubility SOLUBLE IN AQUEOUS BUFFERS < PH 5.5 BUT IS VERY SLIGHTLY SOLUBLE TO INSOLUBLE IN NEUTRAL OR ALKALINE AQUEOUS BUFFERS |
Target TARGET BCR-ABL TYROSINE KINASE PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGF) STEM CELL FACTOR (SCF) C-KIT PDB Ligand code = STI (link to the list of PDB complexes) Download experimental 3D coordinates of STI with added hydrogens |
DrugCentral Platelet-derived growth factor receptor beta UNIPROT P09619 PDGFRB Tyrosine-protein kinase ABL1 UNIPROT P00519 ABL1 |
Download SDF file | 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide Formula: Calculated chemical properties: MW 493.61 NB_atoms 37 XLogP 4.59 PSA 75.246 NB_HD 2 NB_HA 8 fsp3 0.24 Lipinski(0=no;1=yes) 1 |
FDA NDA 021335 (label) INN (IMATINIB MESYLATE) GLEEVEC (NOVARTIS) APPROVAL= AP YEAR= 2001 NEWMOLECULARENTITY DISCONTINUED NDA 021588 (label) INN (IMATINIB MESYLATE) GLEEVEC (NOVARTIS) APPROVAL= AP YEAR= 2003 NDA 078340 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (SUN PHARM) APPROVAL= AP YEAR= 2015 DISCONTINUED NDA 079179 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (APOTEX) APPROVAL= AP YEAR= 2016 NDA 204285 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2016 NDA 204644 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (MYLAN) APPROVAL= AP YEAR= 2017 NDA 206547 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (DR REDDYS) APPROVAL= AP YEAR= 2018 NDA 207586 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (HIKMA) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 205990 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 207495 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 207818 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (NATCO PHARMA LTD) APPROVAL= AP YEAR= 2019 NDA 208302 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (SHILPA) APPROVAL= AP YEAR= 2019 NDA 208429 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (CHARTWELL RX) APPROVAL= AP YEAR= 2019 NDA 210658 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2020 NDA 212773 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2020 NDA 212135 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (QILU PHARM HAINAN) APPROVAL= AP YEAR= 2022 NDA 219097 (label) INN (IMATINIB MESYLATE) IMKELDI (SHORLA ONCOLOGY) APPROVAL= AP YEAR= 2024 NDA 212193 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (CSPC OUYI) APPROVAL= AP YEAR= 2025 NDA 212975 (pdf not found) INN (IMATINIB MESYLATE) IMATINIB MESYLATE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2025 |
Other links: |